PLATELET INHIBITION WITH THE GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST LAMIFIBAN IN HIGH-RISK PATIENT SUBSETS - STUDIES TO DETERMINE THE CORRELATION BETWEEN PLATELET-MEDIATED PROTHROMBOTIC ACTIVITY AND CLINICAL RISK/

Authors
BECKER RC ALI O HARRINGTON RA BALL SP SPENCER FA GORE JM
Citation
Rc. Becker et al., PLATELET INHIBITION WITH THE GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST LAMIFIBAN IN HIGH-RISK PATIENT SUBSETS - STUDIES TO DETERMINE THE CORRELATION BETWEEN PLATELET-MEDIATED PROTHROMBOTIC ACTIVITY AND CLINICAL RISK/, Circulation, 96(8), 1997, pp. 4196-4196
Citations number
NO
Categorie Soggetti
Peripheal Vascular Diseas",Hematology
Journal title
Circulation → ACNP
ISSN journal
00097322
Volume
96
Issue
8
Year of publication
1997
Supplement
S
Pages
4196 - 4196
Database
ISI
SICI code
0009-7322(1997)96:8<4196:PIWTGI>2.0.ZU;2-Q